Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Assessment of Immuno-Histochemical Expression of Mbd1 in Colorectal Adenocarcinoma and Its Correlations With Prognostic Factors Publisher



Ghaedamini S1 ; Nikbakht M1 ; Soleimani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Middle East Journal of Digestive Diseases Published:2020


Abstract

BACKGROUND MBD1, the largest member of methyl binding domain family, has the most downregulated mRNA expression and upregulated methylation levels in advanced colorectal cancer (CRC). In this study, we evaluated the immune-histochemical expression of MBD1 in CRC and assessed its correlation with clinicopathological features to study its prognostic value in CRC. METHODS A total of 60 samples of CRC, from patients who underwent surgical gastroenterology operations, were randomly selected. The samples included one tumor-rich section per case and one adjacent tumor-free section as a normal control for that case. Then, immunohistochemistry (ICH) was performed for MBD1 protein on all samples and the expression of MBD1 was analyzed in cancerous and normal samples. In the next step, the correlation between MBD1 and clinicopathological features including age, sex, location of the tumor, grade, and stage were evaluated. RESULTS The expression of MBD1 protein had a significant downregulation in cancerous samples compared with normal control samples. This downregulation increased corresponding to both grade and stage of cancer. However, no correlation was seen between the expression of MBD1 and sex, age and location of the tumor. CONCLUSION MBD1 protein may be considered as a protein marker in the detection of CRC and its progression. © 2020 The Author(s).
Related Docs
View other Related Docs
1. Ret Protein Expression in Colorectal Cancer; an Immunohistochemical Assessment, Asian Pacific Journal of Cancer Prevention (2021)
2. The Relationship Between Programmed Cell Death Receptor-1 Expression in Colon Tumoral Tissue and Clinical and Pathological Characteristics of Patients With Colon Cancer; [ارتباط بیان گیرنده ی مرگ برنامه ریزی شده 1 در بافت تومورال روده ی بزرگ با ویژگی های بالینی و آسیب شناسی بیماران مبتلا به سرطان روده ی بزرگ], Journal of Isfahan Medical School (2023)
3. Bispecific Antibodies in Colorectal Cancer Therapy: Recent Insights and Emerging Concepts, Immunotherapy (2021)
4. Predictive Value of Tissue Inhibitor of Metalloproteinases-1 and Carcinoembryonic Antigen Plasma Levels in Response to Chemotherapy in Patients With Metastatic Colorectal Cancer, Journal of Research in Medical Sciences (2014)
5. Analysis of Tslc1 Expression in Colorectal Cancer Specimens by Immunohistochemistry, Journal of Isfahan Medical School (2012)
6. Identification of Genes Related to Ribosomal Proteins in Colorectal Cancer: Exploring Their Potential As Biomarkers, Prognostic Indicators, and Therapeutic Targets, Molecular Biology Reports (2024)
7. Leng8-As1: A Prognostic Biomarker in Colorectal Cancer-Differential Expression and Clinical Implications, Indian Journal of Clinical Biochemistry (2024)
8. Comparison of Interleukin 18 Gene Expression and Its Serum Level Between Iranian Colorectal Cancer (Crc) Patients and Healthy People, Biologia (2019)
Experts (# of related papers)
View all Related Experts
Rasoul Salehi (8)
Reza Nedaeinia (4)
Other Related Docs
9. Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: A Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry, Journal of Gastrointestinal Cancer (2021)
10. Mir-196: Emerging of a New Potential Therapeutic Target and Biomarker in Colorectal Cancer, Molecular Biology Reports (2020)
11. Comparative Expression of Breast Cancer 1 Tumor Suppressor Protein in Cancerous and Healthy Colorectal Specimens, Journal of Isfahan Medical School (2016)
12. Study of P33 Tumor Suppressor Protein Expression in Normal and Cancerous Colorectal Tissues, Journal of Isfahan Medical School (2010)
13. Exploring the Role of Interleukin 11 in Cancer Progression, Patient Survival, and Therapeutic Insights, Molecular Biology Reports (2024)
14. Analysis of Sdc2 Gene Promoter Methylation in Whole Blood for Noninvasive Early Detection of Colorectal Cancer, Journal of Cancer Research and Therapeutics (2022)
15. The Effect of Intestinal Microbiota Metabolites on Ht29 Cell Line Using Mtt Method in Patients With Colorectal Cancer, Gastroenterology and Hepatology from Bed to Bench (2019)
16. Immunohistochemical Analysis of Mismatch Repair Proteins in Iranian Colorectal Cancer Patients at Risk for Lynch Syndrome, Iranian Journal of Cancer Prevention (2015)
17. Early Detection of Colorectal Cancer: From Conventional Methods to Novel Biomarkers, Journal of Cancer Research and Clinical Oncology (2016)
18. Evaluation of Cd133 Expression Rate in Colon Cancers With Immunohistochemistry Method and Its Relationship With Colon Cancer Prognosis, Immunopathologia Persa (2024)
19. Promoter Methylation of Matrix Metallopeptidase 9 in Peripheral Blood Mononuclear Cells: A Novel Biomarker in a Promising Source for Noninvasive Colorectal Cancer Diagnosis, Journal of Cancer Research and Therapeutics (2023)
20. An Immunohistochemical Study of Egfr Expression in Colorectal Cancer and Its Correlation With Lymph Nodes Status and Tumor Grade, Journal of Research in Medical Sciences (2012)
21. Identification of Genes With High Heterogeneity of Expression As a Predictor of Different Prognosis and Therapeutic Responses in Colorectal Cancer: A Challenge and a Strategy, Cancer Cell International (2022)
22. Comparative Analysis of Apc Tumor Suppressor Protein Expression in Cancerous and Normal Colorectal Specimens by Immunohistochemistry, Journal of Isfahan Medical School (2012)
23. Status of Integrin Subunit Alpha 4 Promoter Dna Methylation in Colorectal Cancer and Other Malignant Tumors: A Systematic Review and Meta-Analysis, Research in Pharmaceutical Sciences (2023)
24. Tfpi2 and Ndrg4 Gene Promoter Methylation Analysis in Peripheral Blood Mononuclear Cells Are Novel Epigenetic Noninvasive Biomarkers for Colorectal Cancer Diagnosis, Journal of Gene Medicine (2020)
25. A Comparative Survey on the Expression of P16 As a Tumor Suppressor Protein in Cancerous and Non-Cancerous Colorectal Tissue Samples Using Immunohistochemistry Method, Journal of Isfahan Medical School (2012)
26. The Decrease in Nkg2d+ Natural Killer Cells in Peripheral Blood of Patients With Metastatic Colorectal Cancer, Bratislava Medical Journal (2015)
27. Association of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio With Tumoral Differentiation in Colorectal Cancer, Gene Reports (2022)
28. A Prediction of the Crnde Role by Modulating Nf-Κb Pathway in Inflammatory Bowel Disease (Ibd), Biochemistry and Biophysics Reports (2024)
29. Micrometastasis in Colorectal Cancer: Does It Affect Staging?, ANZ Journal of Surgery (2018)
30. The Dysbiosis Signature of Fusobacterium Nucleatum in Colorectal Cancer-Cause or Consequences? a Systematic Review, Cancer Cell International (2021)
31. Association Between Colorectal Cancer and the Degree of Itga4 Promoter Methylation in Peripheral Blood Mononuclear Cells, Gene Reports (2022)
32. The Frequency of Grasp Gene's Promoter Methylation in Colorectal Cancer Tissue Compared With Healthy Surrounding Tissue, Journal of Isfahan Medical School (2021)
33. Integrative Analysis of Dna Methylation and Gene Expression Through Machine Learning Identifies Stomach Cancer Diagnostic and Prognostic Biomarkers, Journal of Cellular and Molecular Medicine (2023)
34. Tim3 and Pd-1 As a Therapeutic and Prognostic Targets in Colorectal Cancer: Relationship With Sidedness, Clinicopathological Parameters, and Survival, Frontiers in Oncology (2023)
35. A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis, Current Therapeutic Research - Clinical and Experimental (2024)
36. The Stromelysin-1 5A/5A Genotype Enhances Colorectal Cancer Cell Invasion in Iranian Population, Journal of Research in Medical Sciences (2012)
37. Exploring Slc30a6 As a Potential Prognostic, Immunomodulatory, and Therapeutic Biomarker in Various Cancers With a Focus on Pancreatic Cancer: A Pan-Cancer Analysis, Egyptian Journal of Medical Human Genetics (2024)
38. The Crosstalk Between Ubiquitin-Conjugating Enzyme E2q1 and P53 in Colorectal Cancer: An in Vitro Analysis, Medical Oncology (2023)
39. Rs12904 Polymorphism in the 3'-Untranslated Region of Ephrin A1 Ligand and the Risk of Sporadic Colorectal Cancer in the Iranian Population, Journal of Cancer Research and Therapeutics (2019)
40. A Comparative Survey on the Expression of Retinoblastoma Protein As a Tumor Suppressor Protein in Cancerous and Non-Cancerous Colorectal Tissue Samples Using Immunohistochemistry Method, Journal of Isfahan Medical School (2012)
41. Novel Biomarkers for Neoplastic Progression From Ulcerative Colitis to Colorectal Cancer: A Systems Biology Approach, Scientific Reports (2023)
42. The Pathogenic Roles of Lncrna-Taurine Upregulated 1 (Tug1) in Colorectal Cancer, Cancer Cell International (2022)
43. Expression and Prognostic Significance of Stem Cell Marker Cd133 in Survival Rate of Patients With Colon Cancer, Oncology and Therapy (2022)
44. Analysing Glycolysis-Related Genes Reveals the Prognostic and Diagnostic Relevance of Ier3 and Agrn in Colorectal Cancer, Genes and Genomics (2025)
45. Evaluation of Promoter Methylation Status of Mlh1 Gene in Iranian Patients With Colorectal Tumors and Adenoma Polyps, Gastroenterology and Hepatology from Bed to Bench (2017)